Thanks to federally funded cancer research and clinical trials at Johns Hopkins, John Ryan has been able to attend graduations and weddings, and witness the birth of his grandchildren
Johns Hopkins neuroscientist Uli Mueller came to the U.S. from Germany decades ago because of the unrivaled opportunities for research and discovery. He worries that cuts to research funding will upend the entire system along with the health and economic benefits it produces.
Decades of clinical trials have drastically improved both life expectancy and quality of life for those with cystic fibrosis, a testament to the pivotal role of clinical trials in advancing medical research and treatment
Hopkins neuroscientist Richard Huganir is close to finding a potential life-changing treatment for kids with SYNGAP1-related disorders, but cuts to federal funding could delay or halt the progress
A genetic mutation and evolutionary trick fuels horses' exceptional athleticism, findings that may advance scientific understanding and treatments for inherited and age-related diseases in people
Falls are the leading cause of injury-related death among seniors in the United States. Johns Hopkins researcher Kathleen Cullen studies the vestibular system in our inner ear, integral to maintaining balance.
National Science Foundation funding helped Suchi Saria develop and launch a lifesaving early warning system that uses artificial intelligence to catch sepsis infections before they become deadly
Engineer Denis Wirtz and colleagues are using artificial intelligence and multiscale imaging to reveal how tumors grow, spread, and vary across populations
Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for a range of diseases, and why federal research cuts risk undermining U.S. scientific leadership in this emerging area